2006 Coding Guidelines and Policy Update Compendium M 526
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Sa G Es 2 0 0 6 Sages Lunches
TABLE OF CONTENTS 1 SAGES Corporate Supporters S 2 Hotel Contact Information THANKS TO OUR 2 General Information about the Meeting A 2 Registration Hours & Information CORPORATE SUPPORTERS: 2 Exhibits and Exhibit Only Registration G 5 SAGES Meeting Leaders PLATINUM LEVEL DONORS 7 SAGES Accreditation & CME Worksheet AUTOSUTURE & VALLEYLAB – E 8 Forde Tribute Dinner DIVISIONS OF TYCO HEALTHCARE 8 Hilton Anatole Floor Plan S 9 SAGES Schedule at a Glance ETHICON ENDO-SURGERY, INC. SAGES 2006 Postgraduate Courses 15 Bariatric Postgraduate Course KARL STORZ ENDOSCOPY-AMERICA, INC. 2 16 Joint SAGES-MIRA Symposium–Robotics 0 35 Colon Postgraduate Course OLYMPUS AMERICA 55 SAGES Allied Health Professionals Course GOLD LEVEL DONORS 0 SAGES 2006 Hands-On Courses 12 Joint IPEG/SAGES Pediatric Fellows Inamed Health 6 Advanced Techniques Hands-On Course Stryker Endoscopy 20 Surgeon in the Digital Age 27 Advanced Skills & Laparoscopic Techniques SILVER LEVEL DONORS Hands-On Course Boston Scientific Endoscopy 28 SAGES/SLS Simulator Hands-on Course Davol, Inc. 31 SAGES Endoluminal Surgery Hands-on Course General Surgery News 18 Joint SAGES/ACS Sessions Gore & Associates, Inc. 18 Inflammatory Bowel Disease 18 The Changing Face of Surgical Education BRONZE LEVEL DONORS 20 Ethicon Patient Safety Lunch Adolor Corporation and GlaxoSmithKline 22 International Video Session: Teleconferenced to Asia Aesculap 23 SAGES Technology Pavillion B-K Medical Systems 27 SAGES/IPEG Combined Video Breakfast Session Cook Surgical 32 SAGES/Fellowship Council Lunch 37 SAGES Hernia Symposium Medtronic 37 SAGES Bariatric Symposium SurgRX 39 SAGES 2006 Scientific Session Synovis Surgical Innovations 41 SAGES Presidential Address Taut, Inc. 43 Gerald Marks Lecture Tissue Science Laboratories 53 Karl Storz Lecture 44 SAGES/IPEG Panel, SAGES/ASGE Panel, Hernia Panel SAGES recognizes TATRC as a Meeting Supporter. -
Computing in Cardiology
COMPUTING IN CARDIOLOGY September 13-16, 2020 Rimini, Italy Table of Contents Sponsors 3 Welcome to CinC@Rimini in 2020! 5 Board of Directors 7 Local Organizing Committee 8 Letter from the President 9 Welcome to Brno for CinC 2021 10 Maps 11 General Map of Rimini 11 Transportation, Hotels and Practical Information 14 Transportation 14 By air 14 By car 14 By train 14 Local Transportation in Rimini 15 By bus 15 By bike 15 Practical Information 16 Climate 16 Money/currency 16 Emergency phone numbers 16 Electric standards 16 Language 17 Time Zones 17 Mobile Phones 17 Safety and Security 17 COVID-19 emergency – Main general rules in Emilia - Romagna 17 COVID-19 emergency – Safety rules and procedures at Palacongressi 18 Internet Access 19 Computing in Cardiology 2020 1 Meals 20 Accompanying Persons (Guests) 20 Conference Information 21 General Information 21 Sunday Symposium 21 Programme outline 21 Conference site 22 Monday Social Program 23 Activist program 23 Passivist program 24 For Authors and Speakers 25 Oral presentations 25 IN PERSON oral presentations 25 REMOTE oral presentations 26 Q&A during oral presentations 26 Poster presentations 26 IN PERSON poster session 26 REMOTE poster session 27 Rosanna Degani Young Investigator Award 28 Clinical Needs Translational (CTA) Award 28 PhysioNet/Computing in Cardiology Challenge 2020 28 Maastricht Simulation Award (MSA) 29 Deadlines 29 Manuscripts 29 Scientific Program Details 31 Program Overview 2 Computing in Cardiology 2020 Sponsors Computing in Cardiology 2020 is supported by several institutions, companies and academic partnerships. The Local Organizing Committee would like to thank the following partners: Computing in Cardiology 2020 3 4 Computing in Cardiology 2020 Welcome to CinC@Rimini in 2020! Dear Colleagues and Friends, On behalf of the Local Organizing Committee, we warmly welcome you to Computing in Cardiology 2020. -
Large Animal Surgical Procedures As-Of December 1, 2020 Abdominal
Large Animal Surgical Procedures as-of December 1, 2020 Core Curriculum Category Surgical Category Surgical Procedure Diaphragmatic herniorrhaphy Exploratory celiotomy - left flank Exploratory celiotomy - right flank Abdominal cavity/wall Exploratory celiotomy - ventral midline Exploratory celiotomy - ventral paramedian Exploratory laparotomy - death / euthanasia on table Peritoneal lavage via celiotomy Cecocolostomy Ileo-/Jejunocolostomy Cecum Jejunocecostomy Typhlectomy, partial Typhlotomy Abomasopexy, laparoscopic Abomasopexy, left flank Abdominal - LA Abomasopexy, paramedian Food animal GI: Abomasum Abomasotomy Omentopexy Pyloropexy, flank Reduction of volvulus Typhlectomy Food animal GI: Cecum Typhlotomy Food animal GI: Descending colon, Rectal prolapse, amputation/anastomosis rectum Rectal prolapse, submucosal reduction Food animal GI: Rumen Rumenotomy Decompression/emptying (no enterotomy) Food animal GI: Small intestine Enterotomy Reduction w/o resection (incarceration, volvulus, etc.) Resection/anastomosis Enterotomy Reduction of displacement Food animal GI: Spiral colon Reduction of volvulus Resection/anastomosis (inc. atresia coli) Side-side anastomosis, no resection Colopexy, hand-sutured Colopexy, laparoscopic Colostomy Large colon Enterotomy Reduction of displacement Reduction of volvulus Resection/anastomosis Biopsy Liver Cholelith removal Liver lobectomy Laceration repair Rectum Rectal prolapse repair Resection/anastomosis Enterotomy Impaction resolution via celiotomy Small colon Resection/anastomosis Taeniotomy Decompression/emptying -
Clinical Guideline Experimental Or Investigational Services
Clinical Guideline Guideline Number: CG012, Ver. 6 Experimental or Investigational Services Disclaimer Clinical guidelines are developed and adopted to establish evidence-based clinical criteria for utilization management decisions. Oscar may delegate utilization management decisions of certain services to third-party delegates, who may develop and adopt their own clinical criteria. Clinical guidelines are applicable to certain plans. Clinical guidelines are applicable to members enrolled in Medicare Advantage plans only if there are no criteria established for the specified service in a Centers for Medicare & Medicaid Services (CMS) national coverage determination (NCD) or local coverage determination (LCD) on the date of a prior authorization request. Services are subject to the terms, conditions, limitations of a member’s policy and applicable state and federal law. Please reference the member’s policy documents (e.g., Certificate/Evidence of Coverage, Schedule of Benefits) or contact Oscar at 855-672-2755 to confirm coverage and benefit conditions. Summary The services referenced in this Clinical Guideline are considered experimental or investigational and are therefore not covered by Oscar. The services referenced in this Clinical Guideline may not be all- inclusive. Specific benefit plan documents (e.g., Certificate of Coverage, Schedule of Benefits) and federal or state mandated health benefits and laws take precedence over this Clinical Guideline. A service considered experimental or investigational when its safety and efficacy has been established. They may have outcomes that are inferior to standard medical treatment, for which long-term clinical utility has been established. To determine whether a service, device, treatment or procedure has proven safety and efficacy, the available reliable evidence is reviewed, which may include but is not limited to (listed in order of decreasing reliability): 1. -
Fearful Symmetries: Essays and Testimonies Around Excision and Circumcision. Rodopi
Fearful Symmetries Matatu Journal for African Culture and Society ————————————]^——————————— EDITORIAL BOARD Gordon Collier Christine Matzke Frank Schulze–Engler Geoffrey V. Davis Aderemi Raji–Oyelade Chantal Zabus †Ezenwa–Ohaeto TECHNICAL AND CARIBBEAN EDITOR Gordon Collier ———————————— ]^ ——————————— BOARD OF ADVISORS Anne V. Adams (Ithaca NY) Jürgen Martini (Magdeburg, Germany) Eckhard Breitinger (Bayreuth, Germany) Henning Melber (Windhoek, Namibia) Margaret J. Daymond (Durban, South Africa) Amadou Booker Sadji (Dakar, Senegal) Anne Fuchs (Nice, France) Reinhard Sander (San Juan, Puerto Rico) James Gibbs (Bristol, England) John A. Stotesbury (Joensuu, Finland) Johan U. Jacobs (Durban, South Africa) Peter O. Stummer (Munich, Germany) Jürgen Jansen (Aachen, Germany) Ahmed Yerma (Lagos, Nigeria)i — Founding Editor: Holger G. Ehling — ]^ Matatu is a journal on African and African diaspora literatures and societies dedicated to interdisciplinary dialogue between literary and cultural studies, historiography, the social sciences and cultural anthropology. ]^ Matatu is animated by a lively interest in African culture and literature (including the Afro- Caribbean) that moves beyond worn-out clichés of ‘cultural authenticity’ and ‘national liberation’ towards critical exploration of African modernities. The East African public transport vehicle from which Matatu takes its name is both a component and a symbol of these modernities: based on ‘Western’ (these days usually Japanese) technology, it is a vigorously African institution; it is usually -
Lung Abscess: Analysis of 252 Consecutive Cases Diagnosed Between 1968 and 2004
136 Moreira JS, Camargo JJP, Felicetti JC, Goldenfun PR, Moreira ALS, Porto NS Artigo Original Abscesso pulmonar de aspiração: análise de 252 casos consecutivos estudados de 1968 a 2004* Lung abscess: analysis of 252 consecutive cases diagnosed between 1968 and 2004 JOSÉ DA SILVA MOREIRA1, JOSÉ DE JESUS PEIXOTO CAMARGO2, JOSÉ CARLOS FELICETTI2, PAULO ROBERTO GOLDENFUN3, ANA LUIZA SCHNEIDER MOREIRA4, NELSON DA SILVA PORTO2 RESUMO Objetivo: Apresentar a experiência de um serviço especializado em doenças respiratórias no manejo de casos de abscesso pulmonar de aspiração. Métodos: Descrevem-se aspectos diagnósticos e resultados terapêuticos de 252 casos consecutivos de pacientes com abscesso de pulmão, hospitalizados de 1968 a 2004. Resultados: Dos 252 casos, 209 ocorreram em homens e 43 em mulheres, com média de idade de 41,4 anos. Eram alcoolistas 70,2% dos pacientes. Tosse, expectoração, febre e comprometimento do estado geral ocorreram em mais de 97% dos casos, 64% tinham dor torácica, 30,2% hipocratismo digital, 82,5% apresentavam dentes em mau estado de conservação, 78,6% tiveram episódio de perda de consciência e 67,5% apresentavam odor fétido de secreções broncopulmonares. Em 85,3% dos casos as lesões localizavam-se nos segmentos posterior de lobo superior ou superior de lobo inferior, 96,8% delas unilateralmente. Em 24 pacientes houve associação de empiema pleural (9,5%). Flora mista foi identificada em secreções broncopulmonares ou pleurais em 182 pacientes (72,2 %). Todos os doentes foram inicialmente tratados com antibióticos (principalmente penicilina ou clindamicina) e 98,4 % deles foram submetidos à drenagem postural. Procedimentos cirúrgicos foram efetuados em 52 (20,6%) pacientes (24 drenagens de empiema, 22 ressecções pulmonares e 6 pneumostomias). -
ICD~10~PCS Complete Code Set Procedural Coding System Sample
ICD~10~PCS Complete Code Set Procedural Coding System Sample Table.of.Contents Preface....................................................................................00 Mouth and Throat ............................................................................. 00 Introducton...........................................................................00 Gastrointestinal System .................................................................. 00 Hepatobiliary System and Pancreas ........................................... 00 What is ICD-10-PCS? ........................................................................ 00 Endocrine System ............................................................................. 00 ICD-10-PCS Code Structure ........................................................... 00 Skin and Breast .................................................................................. 00 ICD-10-PCS Design ........................................................................... 00 Subcutaneous Tissue and Fascia ................................................. 00 ICD-10-PCS Additional Characteristics ...................................... 00 Muscles ................................................................................................. 00 ICD-10-PCS Applications ................................................................ 00 Tendons ................................................................................................ 00 Understandng.Root.Operatons..........................................00 -
Assessment of Bronchiectasis by Computed Tomography
Thorax: first published as 10.1136/thx.40.12.920 on 1 December 1985. Downloaded from Thorax 1985;40:920-924 Assessment of bronchiectasis by computed tomography IM MOOTOOSAMY, RH REZNEK, J OSMAN, RSO REES, MALCOLM GREEN From the Departments of Diagnostic Radiology and Chest Medicine, St Bartholomew's Hospital, London ABSTRACT Computed tomography and bronchography were used to assess the distribution of bronchiectasis in 15 lungs from eight patients with clinical features of the disease. Of the 36 lobes adequately displayed by bronchography, 22 were found to have bronchiectasis and 14 were found to be normal by both techniques. Cystic disease was readily identified by computed tomography but the cylindrical and varicose types of bronchiectasis could not be distinguished. Segmental local- isation was less accurate, with agreement between computed tomography and bronchography in 116 out of 130 segments. It is concluded that with a modern high resolution scanner computed tom- ography provides a useful method of assessing lobar distribution in bronchiectasis. The incidence of bronchiectasis in the United King- placing bronchography in a substantial number, dom has decreased since the advent ofantibiotic treat- Muller et al found correspondence in only about half ment and the decline in severe respiratory disease in the lungs studied. childhood. Nevertheless, it still occurs as the result of The purpose of this study is to assess the place of severe pulmonary infections and in association with modern high resolution computed tomography scan-copyright. immune deficiency, cystic fibrosis, and other condi- ners in the clinical management ofpatients with bron- tions. chiectasis and to investigate the accuracy with which The disease is defined as irreversible abnormal di- lobar and segmental disease and the type of disease latation of the bronchi and has been classified by present can be predicted. -
Comparison of Laparoscopic-Guided Abomasopexy Versus Omentopexy Via Right Flank Laparotomy for the Treatment of Left Abomasal Displacement in Dairy Cows
Comparison of laparoscopic-guided abomasopexy versus omentopexy via right flank laparotomy for the treatment of left abomasal displacement in dairy cows Torsten Seeger, Dr Med Vet; Harald Kümper, Dr Med Vet; Klaus Failing, Dr Rer Nat; Klaus Doll, Dr Med Vet Habil mean lactation incidence is approximately 1% to 5% Objective—To compare results obtained by use of 3–7 laparoscopy-assisted abomasopexy versus omen- but is > 10% in some herds. Various surgical proce- topexy via right flank laparotomy for the treatment of dures have been used, all of which have specific advan- dairy cows with left displaced abomasum (LDA). tages and disadvantages. Open surgical techniques Animals—120 dairy cows with an LDA. include abomasopexy via the ventral paramedian approach8; laparotomy via the left paralumbar fossa for Procedure—In a prospective clinical trial, cows were omentopexy9 and abomasopexy,10 respectively; and randomly allocated to the abomasopexy group omentopexy via laparotomy in the right paralumbar (laparoscopy-assisted abomasopexy) or to the control 11 group (omentopexy via right flank). Data were fossa. Omentopexy via laparotomy in the right obtained during the first 5 days after surgery and 6 paralumbar fossa is considered the standard procedure weeks and 6 months after surgery. for the treatment of cattle with an LDA in Germany. Results—59 of 60 cows in the abomasopexy group Because of financial and time constraints, percuta- and all 60 cows in the control group were treated suc- neous fixation techniques, such as the blind-tack cessfully. Median duration was shorter for the laparo- suture procedure12 or toggle-pin method,13 have scopic procedure (27.5 minutes), compared with that become more commonly used by practitioners, even for the control group (38 minutes). -
Respiratory – Aspiration Precautions SECTION: 9.01 Strength of Evidence Level: 3
Respiratory – Aspiration Precautions SECTION: 9.01 Strength of Evidence Level: 3 PURPOSE: 4. Consult speech therapist for patients with Implement and educate patient/caregiver on precautions dysphagia, as needed, and as ordered by that prevent aspiration. healthcare provider. 5. Consult dietitian for diet evaluation, as needed CONSIDERATIONS: (requires physician’s order). 6. If patient receiving enteral feedings, See Digestive - 1. Precautions should be taken with all patients who Gastrostomy or Jejunostomy Tube Feeding. are unable to protect their airway to prevent the 7. Monitor patient when eating/drinking: involuntary inhalation of foreign substances, such a. Instruct family or caregiver to do the same. as gastric contents, oropharyngeal secretions, b. Observe adequacy of swallowing. food or fluids, into the tracheobronchial passages. c. SN: order ST eval for tube fed patients for 2. Patients at particular risk for aspiration include those swallow eval as appropriate. whose normal protective mechanisms are impaired. 8. Maintain calm environment when the patient is 3. Major risk factors include: eating or drinking. a. Decreased level of consciousness (confusion, 9. If patient is unable to manage own oral secretions, coma, sedation). nasopharyngeal suctioning may be indicated, b. Documented previous episode of aspiration. consult with healthcare provider and refer to c. Neuromuscular disease and structural nasopharyngeal suctioning policy as needed. abnormalities of the aerodigestive tract. 10. Keep wire cutters at HOB of patient with wired jaws d. Depressed protective reflexes (cough or gag). and instruct patient and caregiver in use. e. Presence of an endotracheal tube. 11. Notify healthcare provider immediately for any signs f. Persistently high gastric residual volumes. -
OMENTAL TRANSPLANTATION and CELL CULTURE. By: ROSENDO
OMENTAL TRANSPLANTATION and CELL CULTURE. by: ROSENDO CRIOLLOS, M.D. A thesis submitted to the faculty of Graduate Studies and Research in partial fulfillment of the requirements of the Master of Science Degree. Department of Experimental Surgery, McGill University, MONTREAL. APRIL 1964. (i) P R E F A C E. The tremendous progress in medicine, especially in cardiovascular surgery during the pBst few decades bas promoted development of measures for the control and cure of various anomalies and diseases by surgical means. While the controversy over the different procedures of revascularization for an ischaemic heart still continues, the rate of surgery in the management of the occlusive coronary artery disease is widely accepted; as James Bryce so ably said, WMedicine is the only profession that labours incessantly to destroy the reason for its own existence". If this be true allow me to thank Dr. Arthur Vineberg for letting me be one of the labourera in his investigations on free omental grafts as a method to revascularize the ischaemic heart. For the 1~ years that I have expended in the field of research under his supervision I wish to extend my appreciation of his thought provoking discussions on the problems encountered throughout this investigation that lead me to develop a method of scientific thinking. These studies afforded me the opportunity to explore more fully the vascularization activities of the omental tissue in re-establishing itself while set free in ectopie environments which resulted in the finding of a (ii) three day minimum of such free omental grafts to become revascularized. The work certainly has roused my interest and enthusiasm in the importance of experimental medicine, enabling me to complete the training in general surgery with better perspective and understanding. -
Chest Physiotherapy Page 1 of 10
UTMB RESPIRATORY CARE SERVICES Policy 7.3.9 PROCEDURE - Chest Physiotherapy Page 1 of 10 Chest Physiotherapy Effective: 10/12/94 Revised: 04/05/18 Formulated: 11/78 Chest Physiotherapy Purpose To standardize the use of chest physiotherapy as a form of therapy using one or more techniques to optimize the effects of gravity and external manipulation of the thorax by postural drainage, percussion, vibration and cough. A mechanical percussor may also be used to transmit vibrations to lung tissues. Policy Respiratory Care Services provides skilled practitioners to administer chest physiotherapy to the patient according to physician’s orders. Accountability/Training • Chest Physiotherapy is administered by a Licensed Respiratory Care Practitioner trained in the procedure(s). • Training must be equivalent to the minimal entry level in the Respiratory Care Service with the understanding of age specific requirements of the patient population treated. Physician's A written order by a physician is required specifying: Order Frequency of therapy. Lung, lobes and segments to be drained. Any physical or physiological difficulties in positioning patient. Cough stimulation as necessary. Type of supplemental oxygen, and/or adjunct therapy to be used. Indications This therapy is indicated as an adjunct in any patient whose cough alone (voluntary or induced) cannot provide adequate lung clearance or the mucociliary escalator malfunctions. This is particularly true of patients with voluminous secretions, thick tenacious secretions, and patients with neuro- muscular disorders. Drainage positions should be specific for involved segments unless contraindicated or if modification is necessary. Drainage usually in conjunction with breathing exercises, techniques of percussion, vibration and/or suctioning must have physician's order.